Advertisement

Topics

Minerva Biolabs GmbH Company Profile

23:02 EDT 20th June 2018 | BioPortfolio

Minerva Biolabs is committed to providing highest quality in products and services.1999 The company was established in August 1999 as a spin-off from the Robert-Koch Institute (RKI) in Berlin. Minerva Biolabs GmbH started with innovative products for the effective diagnosis and elimination of mycoplasma contamination in cell cultures and biopharmaceuticals.
2000 The transition to a quality management system (QMS) in accordance with ISO 9001:2000 has been made in November 2000.
2001 Based on our experience with the production of high quality and reliable diagnostics for biopharmaceutical quality control, Minerva Biolabs transferred this know-how to the development of clinical diagnostics for respiratory infections in 2001.
2004 The consequential expansion of our product range led in the beginning of 2004 to the introduction of the worldwide first bacterial diagnostic assay. Another innovative improvement followed the same year by the integration of the Aqua Screen® System into the portfolio of contamination control solutions. The Aqua Screen® System provides a highly efficient method for the filtration and detection of legionella in water. The transition to a quality management system in accordance with ISO 13485:2003 has been made in July 2004.

Location

Landhausring 7
Berlin
D-12683
Germany

Contact

Phone: 49 (0)30 2000 437-0
Fax: 49 (0)30 2000 437-9
Email: info@minerva-biolabs.com


News Articles [207 Associated News Articles listed on BioPortfolio]

Minerva Neurosciences, Inc.: Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director

WALTHAM, Mass., 2018-02-05 14:30 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a biopharmaceutical company focused on the development of therapies to treat central nervous syst...

Cleveland BioLabs, Inc: Cleveland Biolabs Announces Progress on European Marketing Authorization Application

BUFFALO, NY / ACCESSWIRE / March 28, 2018 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported that the company has received Day 120 review questions from the European Medicines Agency (EMA) reg...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018

Management to host conference call WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the developme...

Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator

The new location represents an expansion of MBC BioLabs' Bay Area footprint beyond San Francisco, with closer proximity to Silicon Valley and Stanford University Read more...

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

Tufts University and BioLabs today announced the opening of Tufts Launchpad | BioLabs, a full-service biotech facility supporting high-potential, early-stage life sciences startup ventures in the Bost...

Tufts University and BioLabs open coworking laboratory space for life sciences innovators

(Tufts University, Health Sciences Campus) Tufts University and BioLabs announce the opening of Tufts Launchpad | BioLabs, a fully equipped, supported and permitted biotech facility supporting high-po...

Minerva API Insight,2018 [Report Updated: 14022018] Prices from USD $500

IntroductionDelveInsight's, Minerva API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country w...

Minerva Neurosciences, Inc.: Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates

Four late-stage trials underway, targeting schizophrenia, major depressive disorder and insomnia disorder Planning for commercialization moves forward Management to host conference call today at 8...

PubMed Articles [72 Associated PubMed Articles listed on BioPortfolio]

A year in review in Minerva Anestesiologica 2017 Critical Care: experimental and clinical studies.

Alfalfa and Pastures: Sources of Pests or Generalist Natural Enemies?

Pierce's disease of grapevine and almond leaf scorch disease are both caused by the bacterial pathogen Xylella fastidiosa Wells et al. In the Central Valley of California, Draeculacephala minerva Ball...

Effects of Minerva Orthosis on Larynx Height in Young, Healthy Volunteers.

During speech, larynx is higher in the neck for high-pitched sounds and lower for low-pitched sounds. Patients with different problems in cervical and cervicothoracic spine use cervical orthosis to li...

We need to harmonize our languages!

Over-using oncoplastic breast surgery.

Clinical Trials [47 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure

The aim of this study is to test the impact of the managed ventricular pacing (MVP) mode and atrial preventive and antitachycardia pacing therapies on the reduction of a composite clinical...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events wil...

Companies [548 Associated Companies listed on BioPortfolio]

Minerva Biolabs GmbH

Minerva Biolabs is committed to providing highest quality in products and services.1999 The company was established in August 1999 as a spin-off from the Robert-Koch Institute (RKI) in Berlin. Minerva...

Minerva Pharmaceuticals

Minerva Pharmaceuticals, Inc. is a biopharmaceutical product development company dedicated to detecting and eliminating cancer before clinical symptoms occur.

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth ...

Torrey Pines Biolabs

Chemokine.com is a product line from Torrey Pines Biolabs, Inc. established in San Diego, California, have been moved to Houston, Texas since January 2001. Torrey Pines Biolabs is an emerging biotechn...

Pacific BioLabs

Pacific BioLabs is an independent laboratory with over 25 years experience providing cGMP/GLP testing services to companies in the Pharmaceutical, Biopharm, Medical Device, Diagnostic and OECD/EPA reg...

More Information about "Minerva Biolabs GmbH" on BioPortfolio

We have published hundreds of Minerva Biolabs GmbH news stories on BioPortfolio along with dozens of Minerva Biolabs GmbH Clinical Trials and PubMed Articles about Minerva Biolabs GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Minerva Biolabs GmbH Companies in our database. You can also find out about relevant Minerva Biolabs GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record